Related Experiment Video
Updated: Aug 18, 2025

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Synergistic Antibacterial Effect and Mechanism of Allicin and an Enterobacter cloacae Bacteriophage
Zhi Tao1, Di Geng1, Jiayue Tao1
1School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
Abstract:
Enterobacter cloacae is a troublesome pathogen causing refractory infections of the lower respiratory tract, urethra and abdominal cavity, endocarditis, osteomyelitis, and neonatal septicemia. It is prone to developing resistance to ordinary antibiotics and has brought a serious problem to clinical treatment. An artful synergistic combination of an antibacterial natural product allicin and a newly isolated bacteriophage, named BD523, was constructed herein. This combination significantly lowered effective dosage of allicin and effectually overcame bacterial drug-resistance. We experimentally evidenced that allicin interacts with bacterial DNA in the groove region by inserting itself into the DNA double helix and, subsequently, disrupts the bacterial DNA by cleaving phosphate diester bonds of deoxynucleotides. Further, BD523 destroys the cell wall and membrane of bacteria by synthesizing lyase proteins, including holin and endolysins. Thus, the synergistic effect of the combination benefits from complementary targeting mechanisms of allicin and BD523. They cooperatively act on bacterial DNA, cell wall, and membrane to improve antibacterial efficiency and avoid drug-resistance. IMPORTANCE Bacterial drug-resistance is a serious problem afflicting pharmacologists all over the world. Many strategies have been developed and practiced to overcome it, but almost no one is satisfactory due to the continual change of bacteria. Combinations of antibiotics and bacteriophages are promising because of the cooperation of 2 bacterial killers with distinct mechanisms. The combination of allicin and an Enterobacter cloacae bacteriophage reported herein can significantly improve the effect of allicin against E. cloacae. Its synergistic effect was even superior to the combination of bacteriophage and neomycin, of which the MIC was significantly lower than allicin. It was ascribed to the complementary antibacterial and the possible resistance-proof mechanism of bacteriophage and allicin. This study provided a pragmatic way to conquer the cunning bacterium, and may offer reference for research and development of new bacterial killers.
Insights
A combination of the natural product allicin and bacteriophage BD523 effectively combats drug-resistant Enterobacter cloacae infections. This synergistic approach enhances allicin
Area of Science:
- Microbiology
- Infectious Diseases
- Drug Discovery
Background:
- Enterobacter cloacae is a resilient pathogen causing severe infections.
- Bacterial drug resistance poses a significant clinical challenge.
- Novel strategies are needed to combat resistant bacterial strains.
Purpose of the Study:
- To develop a synergistic combination therapy against Enterobacter cloacae.
- To investigate the combined effects of allicin and bacteriophage BD523.
- To overcome existing antibiotic resistance mechanisms.
Main Methods:
- Synergistic combination of allicin and bacteriophage BD523.
- Experimental validation of antibacterial mechanisms.
- Assessment of Minimum Inhibitory Concentration (MIC) compared to existing treatments.
Main Results:
- The combination significantly reduced the required allicin dosage.
- Bacterial drug resistance was effectively overcome.
- Allicin targets bacterial DNA, while BD523 degrades the cell wall and membrane.
- Synergistic action demonstrated superior efficacy compared to bacteriophage and neomycin.
Conclusions:
- The allicin-bacteriophage BD523 combination offers a potent strategy against Enterobacter cloacae.
- Complementary mechanisms of action enhance antibacterial efficiency and prevent resistance.
- This approach provides a promising alternative for treating refractory bacterial infections.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Gene Regulation in Microbial Communities: Quorum Sensing
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
Viral Replication: Lytic Cycle
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...

